Intel
INTC
Oracle
ORCL
Netflix
NFLX
4
Meta Platforms
META
5
Apple
AAPL
US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 73.640
- +0.380+0.52%
Close Apr 28 16:00 ET
- 73.360
- -0.280-0.38%
Post 16:58 ET
3.68BMarket Cap-16.81P/E (TTM)
74.254High71.240Low904.44KVolume72.750Open73.260Pre Close66.16MTurnover2.56%Turnover RatioLossP/E (Static)49.91MShares74.50052wk High14.99P/B2.60BFloat Cap36.93052wk Low--Dividend TTM35.37MShs Float742.500Historical High--Div YieldTTM4.11%Amplitude0.850Historical Low73.150Avg Price1Lot Size
About Soleno Therapeutics Company
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Company Profile
SymbolSLNO
Company NameSoleno Therapeutics
Listing DateNov 13, 2014
Founded1999
CEODr. Anish Bhatnagar, M.D.
MarketNASDAQ
Employees92
Fiscal Year Ends12-31
Address100 Marine Parkway,Suite 400
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-213-8444
Websitehttp://www.soleno.life
Company Executives
- Name
- Position
- Salary
- Dr. Anish Bhatnagar, M.D.
- Chief Executive Officer and Chairman of the Board
- 51.16M
- Meredith S. Manning
- Chief Commercial Officer
- 7.78M
- James H. Mackaness
- Chief Financial Officer and Principal Accounting Officer
- 8.77M
- Patricia C. Hirano
- Senior Vice President, Regulatory Affairs
- 6.05M
- Kristen Yen
- Senior Vice President, Global Clinical Operations and Patient Advocacy
- --
- Dr. Michael Huang, M.D.
- Senior Vice President, Clinical Development
- --
- Dawn Carter Bir
- Director
- 673.92K
- William G. Harris
- Independent Director
- 360.16K
- Matthew Pauls, J.D.,M.B.A.
- Lead Independent Director
- 354.32K
- Dr. Birgitte Volck, M.D.,PhD
- Independent Director
- 347.66K
- Dr. Andrew Sinclair, PhD
- Independent Director
- 290.16K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025